Cerence (NASDAQ:CRNC) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $0.02 by 700 percent. This is a 300 percent decrease over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $115.076 million which beat the analyst consensus estimate of $114.484 million by 0.52 percent. This is a 126.10 percent increase over sales of $50.896 million the same period last year.